Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hatch

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Gynecologic Oncology|March 22, 2003
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trialMaurie Markman, Tracy Glass, Harriet O Smith, et al.
Cancer|December 1, 1986
Immunohistochemistry of the blood group A,B,H isoantigens and Oxford Ca antigen as prognostic markers for stage IB squamous cell carcinoma of the cervixA C To, S J Soong, H M Shingleton, et al.
Archives of Dermatology|March 1, 1986
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantarisJ C Vance, B J Bart, R C Hansen, et al.
Medical Education|March 16, 2002
The assessment of poorly performing doctors: the development of the assessment programmes for the General Medical Council's Performance ProceduresL Southgate, J Cox, T David, et al.
American Journal of Obstetrics and Gynecology|March 11, 1992
Oral folic acid supplementation for cervical dysplasia: a clinical intervention trialC E Butterworth, K D Hatch, S J Soong, et al.
Gynecologic Oncology|March 1, 1987
CA125 as a serum marker for poor prognosis in ovarian malignanciesR D Alvarez, A To, L R Boots, et al.
Journal of Clinical Immunology|July 1, 1987
Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activityR Cauda, S K Tyring, C E Grossi, et al.
Medical Education|March 16, 2002
The General Medical Council's Performance Procedures: peer review of performance in the workplaceL Southgate, J Cox, T David, et al.
Gynecologic Oncology|April 1, 1981
Perioperative influences on infectious morbidity in radical hysterectomyW J Mann, J W Orr, H M Shingleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group studyW P McGuire, J Arseneau, J A Blessing, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Gynecologic Oncology|March 22, 2003
Phase II trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage IV ovarian, fallopian tube, and peritoneal cancers: a Southwest Oncology Group trialMaurie Markman, Tracy Glass, Harriet O Smith, et al.
Cancer|December 1, 1986
Immunohistochemistry of the blood group A,B,H isoantigens and Oxford Ca antigen as prognostic markers for stage IB squamous cell carcinoma of the cervixA C To, S J Soong, H M Shingleton, et al.
Archives of Dermatology|March 1, 1986
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantarisJ C Vance, B J Bart, R C Hansen, et al.
Medical Education|March 16, 2002
The assessment of poorly performing doctors: the development of the assessment programmes for the General Medical Council's Performance ProceduresL Southgate, J Cox, T David, et al.
American Journal of Obstetrics and Gynecology|March 11, 1992
Oral folic acid supplementation for cervical dysplasia: a clinical intervention trialC E Butterworth, K D Hatch, S J Soong, et al.
Gynecologic Oncology|March 1, 1987
CA125 as a serum marker for poor prognosis in ovarian malignanciesR D Alvarez, A To, L R Boots, et al.
Journal of Clinical Immunology|July 1, 1987
Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activityR Cauda, S K Tyring, C E Grossi, et al.
Medical Education|March 16, 2002
The General Medical Council's Performance Procedures: peer review of performance in the workplaceL Southgate, J Cox, T David, et al.
Gynecologic Oncology|April 1, 1981
Perioperative influences on infectious morbidity in radical hysterectomyW J Mann, J W Orr, H M Shingleton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group studyW P McGuire, J Arseneau, J A Blessing, et al.
Pageof 30